Skip to content

Duality Biotherapeutics, Inc.

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2021

    Duality Biologics completes $90 million Series B financing

    Duality Biologics announced that it had completed a $90 million Series B financing led by Lilly Asia Ventures, with other funds participating. The proceeds are primarily intended to support preclinical research, clinical development and product licensing across the company’s pipeline.